Semi-Annual Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7718392

Concept 2018-04-01 to
2018-09-30
As at
2018-09-30
As at
2018-03-31
2017-04-01 to
2017-09-30
As at
2017-09-30
As at
2017-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
11,518,000,000 JPY
13,751,000,000 JPY
Interest and dividends received
185,000,000 JPY
174,000,000 JPY
Interest paid
-8,000,000 JPY
-8,000,000 JPY
Income taxes paid
-4,655,000,000 JPY
-2,831,000,000 JPY
Net cash provided by (used in) operating activities
7,040,000,000 JPY
11,086,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-613,000,000 JPY
-497,000,000 JPY
Purchase of investment securities
-1,000,000 JPY
-1,000,000 JPY
Other, net
-448,000,000 JPY
-214,000,000 JPY
Net cash provided by (used in) investing activities
-1,217,000,000 JPY
-822,000,000 JPY
Cash flows from financing activities
Dividends paid
-3,021,000,000 JPY
-3,063,000,000 JPY
Net cash provided by (used in) financing activities
-6,541,000,000 JPY
-6,500,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-718,000,000 JPY
3,763,000,000 JPY
Cash and cash equivalents
51,976,000,000 JPY
52,694,000,000 JPY
47,530,000,000 JPY
43,767,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.